Susquehanna International Group
LYEL icon

Susquehanna International Group’s Lyell Immunopharma LYEL Stock Holding History

Susquehanna International Group’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.22M Buy
310,198
+159,182
+105% +$3.72M ﹤0.01% 3862
2025
Q4 		$4.65M Buy
151,016
+134,857
+835% +$3.02M ﹤0.01% 4140
2025
Q3 		$262K Buy
+16,159
New +$185K ﹤0.01% 10429
2025
Q2 		– Sell
-11,747
Closed -$107K – 13281
2025
Q1 		$126K Buy
11,747
+2,540
+28% +$31.1K ﹤0.01% 11363
2024
Q4 		$118K Buy
9,207
+3,241
+54% +$64.2K ﹤0.01% 11210
2024
Q3 		$165K Buy
+5,966
New +$175K ﹤0.01% 10656
2024
Q2 		– Sell
-14,129
Closed -$630K – 12752
2024
Q1 		$630K Sell
14,129
-9,840
-41% -$421K ﹤0.01% 7956
2023
Q4 		$930K Buy
23,969
+14,125
+143% +$509K ﹤0.01% 7160
2023
Q3 		$289K Buy
9,844
+189
+2% +$8.97K ﹤0.01% 9425
2023
Q2 		$614K Sell
9,655
-1,341
-12% -$74.2K ﹤0.01% 7830
2023
Q1 		$519K Buy
10,996
+8,230
+298% +$440K ﹤0.01% 8468
2022
Q4 		$192K Sell
2,766
-3,295
-54% -$327K ﹤0.01% 10187
2022
Q3 		$889K Buy
+6,061
New +$821K ﹤0.01% 6940
2022
Q2 		– Sell
-2,213
Closed -$223K – 13518
2022
Q1 		$223K Buy
2,213
+1,698
+330% +$206K ﹤0.01% 10974
2021
Q4 		$80K Sell
515
-1,086
-68% -$242K ﹤0.01% 12284
2021
Q3 		$474K Buy
+1,601
New +$480K ﹤0.01% 9528

Other funds holding LYEL

AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
GP
GSK plc London $599M AUM
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $267M AUM 5.05% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group's LYEL Position: Q1 2026 in Review

Susquehanna International Group increased its Lyell Immunopharma (LYEL) stake by 105% in Q1 2026, buying an estimated $3.72M and bringing the position to 310,198 shares worth $6.22M. The position accounts for ﹤0.01% of the portfolio, ranked #3862.

Susquehanna International Group first reported a position in LYEL in Q3 2021 and has held it in 16 quarters since. 74 funds tracked by Wall St. Rank hold LYEL as of Q1 2026.

  • Susquehanna International Group held 310,198 shares of Lyell Immunopharma worth $6.22M as of Q1 2026.
  • Susquehanna International Group bought 159,182 Lyell Immunopharma shares in Q1 2026, an estimated $3.72M.
  • Lyell Immunopharma made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #3862 holding.
  • Susquehanna International Group first reported a position in Lyell Immunopharma in Q3 2021 and has held it in 16 quarters since.
  • 74 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.